Company
Dr. Reddy's Laboratories
140 Legal Matters
78
33
29

Dr. Reddy's Laboratories Company IP Overview

Practice Areas
Recent StatisticsView All
Subscription-Only
View Concierge Program
PatentsView All
Patents Issued Each Year
TrademarksView All
Trademark Applications Filed Each Year
LitigationView All
Cases Filed Each Year
Pedram Sameni
Patexia Insight 153: Top ANDA Firms of 2022
Pedram Sameni
Sep 29, 2022
Last August, we published our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape and focused... Read More
Pedram Sameni
Patexia Insight 152: Best Performing Brand and Generic Pharmas of 2022 (ANDA)
Pedram Sameni
Sep 22, 2022
Last month, we released our third annual ANDA Litigation Intelligence Report evaluating all stakeholders in ANDA/Hatch-Waxman cases filed over the... Read More
Mikele Bicolli
AstraZeneca vs Dr. Reddy's, When Brand and Generic Sue Over Trademark Infringement
Mikele Bicolli
Aug 15, 2022
  The FDA evaluates the generic versions of a drug and approves them only if studies show that it is... Read More
Practice Areas
PatentsView All
Patents Issued Each Year
LitigationView All
Cases Filed Each Year
Recent StatisticsView All
Subscription-Only
View Concierge Program
TrademarksView All
Trademark Applications Filed Each Year
Pedram Sameni
Patexia Insight 153: Top ANDA Firms of 2022
Pedram Sameni
Sep 29, 2022
Last August, we published our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape and focused... Read More
Pedram Sameni
Patexia Insight 152: Best Performing Brand and Generic Pharmas of 2022 (ANDA)
Pedram Sameni
Sep 22, 2022
Last month, we released our third annual ANDA Litigation Intelligence Report evaluating all stakeholders in ANDA/Hatch-Waxman cases filed over the... Read More
Mikele Bicolli
AstraZeneca vs Dr. Reddy's, When Brand and Generic Sue Over Trademark Infringement
Mikele Bicolli
Aug 15, 2022
  The FDA evaluates the generic versions of a drug and approves them only if studies show that it is... Read More